the trail Generic Diprolene Availability See also: Generic Diprolene AF Diprolene is a brand name of betamethasone topical , approved by the FDA in the following formulation(s): DIPROLENE (betamethasone dipropionate - cream, augmented;topical) Manufacturer: SCHERING Approval date: January 31, 1986 Strength(s): EQ 0.05% BASE DIPROLENE (betamethasone dipropionate - gel, augmented;topical) Manufacturer: SCHERING Approval date: November 22, 1991 Strength(s): EQ 0.05% BASE DIPROLENE (betamethasone dipropionate - lotion, augmented;topical) Manufacturer: MERCK SHARP DOHME Approval date: August 1, 1988 Strength(s): EQ 0.05% BASE [ RLD ] [ AB ] DIPROLENE (betamethasone dipropionate - ointment, augmented;topical) Manufacturer: MERCK SHARP DOHME Approval date: July 27, 1983 Strength(s): EQ 0.05% BASE [ RLD ] [ AB ] Has a generic version of Diprolene been approved? Yes. The following products are equivalent to Diprolene: betamethasone dipropionate lotion, augmented;topical Manufacturer: FOUGERA PHARMS Approval date: May 21, 2007 Strength(s): EQ 0.05% BASE [ AB ] Manufacturer: TARO Approval date: May 21, 2007 Strength(s): EQ 0.05% BASE [ AB ] betamethasone dipropionate ointment, augmented;topical Manufacturer: ACTAVIS MID ATLANTIC Approval date: August 31, 1995 Strength(s): EQ 0.05% BASE [ AB ] Manufacturer: FOUGERA PHARMS Approval date: June 22, 1999 Strength(s): EQ 0.05% BASE [ AB ] Manufacturer: TARO Approval date: October 12, 2004 Strength(s): EQ 0.05% BASE [ AB ] Manufacturer: TELIGENT PHARMA INC Approval date: November 9, 2017 Strength(s): EQ 0.05% BASE [ AB ] Note : No generic formulation of the following products are available. betamethasone dipropionate - cream, augmented;topical betamethasone dipropionate - gel, augmented;topical Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Diprolene. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication. See also: Generic Drug FAQs . Print this page Add to My Med List More about Diprolene (betamethasone topical) Side Effects During Pregnancy or Breastfeeding Dosage Information Drug Interactions Support Group Pricing & Coupons En Español 2 Reviews Add your own review/rating Generic Availability Drug class: topical steroids Consumer resources Diprolene Other brands: Valisone , Diprosone , Betamethacot , Luxiq , ... +6 more Professional resources Diprolene (FDA) Diprolene Lotion (FDA) Betamethasone topical (AHFS Monograph) Other Formulations Diprolene AF Related treatment guides Dermatological Disorders Atopic Dermatitis Dermatitis Lichen Planus Lichen Sclerosus Glossary Term Definition Drug Patent A drug patent is assigned by the U.S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation. Drug Exclusivity Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant. RLD A Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA). By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart. AB Products meeting necessary bioequivalence requirements. Multisource drug products listed under the same heading (i.e., identical active ingredients(s), dosage form, and route(s) of administration) and having the same strength (see Therapeutic Equivalence-Related Terms, Pharmaceutical Equivalents) generally will be coded AB if a study is submitted demonstrating bioequivalence. In certain instances, a number is added to the end of the AB code to make a three character code (i.e., AB1, AB2, AB3, etc.). Three-character codes are assigned only in situations when more than one reference listed drug of the same strength has been designated under the same heading. Two or more reference listed drugs are generally selected only when there are at least two potential reference drug products which are not bioequivalent to each other. If a study is submitted that demonstrates bioequivalence to a specific listed drug product, the generic product will be given the same three-character code as the reference listed drug it was compared against. Drug Status Rx Availability Prescription only C Pregnancy Category Risk cannot be ruled out N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Diprolene Rating 2 User Reviews 6.7 /10 2 User Reviews 6.7 Rate it! Manufacturer Merck & Co., Inc. Drug Class Topical steroids Recently Approved Admelog Admelog (insulin lispro) is a follow-on insulin product (referenced to Humalog) for the treatment... Sinuva Sinuva (mometasone furoate) is a corticosteroid-eluting sinus implant indicated for the treatment... Lonhala Magnair Lonhala Magnair (glycopyrrolate) is a long-acting muscarinic antagonist (LAMA) bronchodilator for... Ozempic Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) analog administered once-weekly for the... More now and again
personalised presents Generic Diprolene Availability the fact
EmoticonEmoticon